4//SEC Filing
Cullen Michael T. 4
Accession 0001437749-19-013383
CIK 0001029125other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:53 PM ET
Size
7.4 KB
Accession
0001437749-19-013383
Insider Transaction Report
Form 4
Cullen Michael T.
Director
Transactions
- Conversion
Common Stock
2019-06-30+10,495→ 167,995 total - Conversion
Convertible Promissory Note
2019-06-30−35,000→ 0 totalExercise: $3.50From: 2018-12-31Exp: 2019-06-30→ Common Stock (10,495 underlying)
Holdings
- 194,576(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]All amounts due under the note automatically converted into shares of common stock of the Issuer based on conversion price of $3.50 per share upon maturity.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001652996
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:53 PM ET
- Size
- 7.4 KB